Teleflex Publishes 2025 Global Impact Report

Key Terms

global reporting initiative regulatory

A global reporting initiative is a widely used set of standards and guidelines companies follow to disclose their environmental, social and governance performance—think of it as a common recipe that helps firms report on things like emissions, labor practices and supply‑chain impacts in a consistent way. Investors use these reports to compare companies, assess long‑term risks and spot opportunities that aren't visible in financial statements alone.

sustainability accounting standards board regulatory

A Sustainability Accounting Standards Board is an independent organization that creates clear, industry-specific rules for companies to report sustainability information that could affect their financial performance, such as environmental impact, social practices, or governance. For investors it acts like a standardized checklist or recipe, making it easier to compare companies, spot risks and opportunities tied to sustainability, and include those factors in investment decisions.

taskforce on climate-related financial disclosures regulatory

A set of voluntary guidelines created to help companies report how climate change could affect their finances and operations, covering risks (like severe weather or policy changes) and opportunities (like new low‑carbon products). For investors it acts like a common checklist and map, making it easier to compare companies’ exposure and preparedness for climate-related impacts and to make informed decisions about risk and value.

physical climate risk assessment technical

An evaluation of how current and future weather and climate hazards—such as floods, storms, heatwaves, droughts, and sea‑level rise—could physically affect a company’s assets, operations, and supply chains. It uses historical data, climate models and scenario analysis to estimate potential damage, downtime and changes in asset value; for investors it serves like a detailed home inspection for a portfolio, helping reveal exposure that can alter expected costs, cash flows and valuation.

scope 1 and 2 ghg emissions technical

Scope 1 and 2 GHG emissions are the carbon and other greenhouse gases a company creates directly and indirectly from its operations: scope 1 covers emissions from sources the company owns or controls (like fuel burned in company vehicles or boilers), while scope 2 covers emissions tied to purchased electricity, heat or steam. Investors care because these figures show operational carbon intensity, potential regulatory or cost risks, and where efficiency improvements can cut both emissions and expenses—think of scope 1 as your home’s furnace and scope 2 as the electricity you buy from the grid.

global health equity statement regulatory

A global health equity statement is a public, formal pledge by a company describing how it will help ensure fair access to healthcare products and services around the world, covering issues like pricing, licensing, research priorities, clinical trial inclusion, and distribution strategies. It matters to investors because it signals how the company manages reputational and regulatory risk, aligns with global policy and patient needs, and plans to sustain long‑term market access—like a company’s public roadmap for sharing its health products and responsibilities.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program

WAYNE, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2025 Global Impact Report. The report outlines recent accomplishments and future plans to support the Company’s Corporate Social Responsibility (CSR) program. The report aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB), and Taskforce on Climate-Related Financial Disclosures (TCFD).

“This year’s Global Impact Report reflects the role Teleflex plays beyond doing business. It showcases the important and tangible impact we’re making in communities, for our environment, and for our people,” said Cam Hicks, Corporate Vice President and Chief Human Resources Officer. “As the Chair of our CSR Steering Committee, it’s an honor to see the progress we make year over year as we continue to live our purpose to improve the health and quality of people’s lives.”

The 2025 Global Impact Report outlines accomplishments and plans for each of the company’s four CSR pillars: Community & Sustainable Healthcare, Planet & Environment, People, and Ethics & Governance.

Highlights from this year’s report include:

• Climate Risk Assessment: Conducted a Physical Climate Risk Assessment to gain a deeper understanding of exposure to physical climate hazards across our operations and supply chain.
• Environmental improvements: We continue to make progress on our environmental ambitions including a 41% reduction in hazardous waste, 45% reduction in gas usage and 23% reduction in scope 1 and 2 GHG emissions – all since 2019.
• Global Health Equity Statement: Created a new Global Health Equity Statement that reflects our objective to enable a greater number of individuals to reach their full health potential.

Read the full 2025 Global Impact Report at https://teleflex.com/usa/en/about-us/csr/index.html.

About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.

At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.
© 2026 Teleflex Incorporated. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260707212108/en/

Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836

Source: Teleflex Incorporated